The psychological impact of breast and ovarian cancer preventive options in BRCA1 and BRCA2 mutation carriers

C. Borreani, S. Manoukian, E. Bianchi, C. Brunelli, B. Peissel, A. Caruso, G. Morasso, M. A. Pierotti

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

This study was performed to describe the impact of preventive options on the psychological condition of BRCA1/BRCA2 carriers. A sample of 52 cancer-affected (C-A) and 27 cancer-unaffected (C-UN) women were enrolled after gene test disclosure (T0). Psychological evaluations were performed at T0 and 15months later (T1). The surgical options were more likely to be chosen in C-A women (62%), although a consistent proportion of C-UN women (30%) also opt for these preventive measures. At the baseline, both samples had average anxiety and depression scores below the cut-off value, restrained average cancer worry scores and a risk perception consistent with the risk percentage provided during genetic counselling. The longitudinal results indicated no clinically meaningful variations in the anxiety and depression scores in either of the two samples. Statistically significant reductions in cancer-risk perception emerged in women who chose surgery in both C-A and C-UN women. In BRCA1/BRCA2 mutation carriers, surveillance does not influence their initial psychological condition, whereas prophylactic surgery has a significant impact in reducing the perceived risk and worry about getting sick. C-A and C-UN women have to be considered as two separate populations of BRCA mutation carriers requiring personalized approaches to risk management.

Original languageEnglish
Pages (from-to)7-15
Number of pages9
JournalClinical Genetics
Volume85
Issue number1
DOIs
Publication statusPublished - Jan 2014

Fingerprint

Ovarian Neoplasms
Breast Neoplasms
Psychology
Mutation
Neoplasms
Anxiety
Depression
Genetic Counseling
Disclosure
Risk Management

Keywords

  • BRCA1/BRCA2
  • Breast cancer
  • Ovarian cancer
  • Prophylactic surgery
  • Psychological impact
  • Risk perception

ASJC Scopus subject areas

  • Genetics(clinical)
  • Genetics

Cite this

The psychological impact of breast and ovarian cancer preventive options in BRCA1 and BRCA2 mutation carriers. / Borreani, C.; Manoukian, S.; Bianchi, E.; Brunelli, C.; Peissel, B.; Caruso, A.; Morasso, G.; Pierotti, M. A.

In: Clinical Genetics, Vol. 85, No. 1, 01.2014, p. 7-15.

Research output: Contribution to journalArticle

Borreani, C. ; Manoukian, S. ; Bianchi, E. ; Brunelli, C. ; Peissel, B. ; Caruso, A. ; Morasso, G. ; Pierotti, M. A. / The psychological impact of breast and ovarian cancer preventive options in BRCA1 and BRCA2 mutation carriers. In: Clinical Genetics. 2014 ; Vol. 85, No. 1. pp. 7-15.
@article{6f5791e5ae6d4832ae848f3f2de09bf9,
title = "The psychological impact of breast and ovarian cancer preventive options in BRCA1 and BRCA2 mutation carriers",
abstract = "This study was performed to describe the impact of preventive options on the psychological condition of BRCA1/BRCA2 carriers. A sample of 52 cancer-affected (C-A) and 27 cancer-unaffected (C-UN) women were enrolled after gene test disclosure (T0). Psychological evaluations were performed at T0 and 15months later (T1). The surgical options were more likely to be chosen in C-A women (62{\%}), although a consistent proportion of C-UN women (30{\%}) also opt for these preventive measures. At the baseline, both samples had average anxiety and depression scores below the cut-off value, restrained average cancer worry scores and a risk perception consistent with the risk percentage provided during genetic counselling. The longitudinal results indicated no clinically meaningful variations in the anxiety and depression scores in either of the two samples. Statistically significant reductions in cancer-risk perception emerged in women who chose surgery in both C-A and C-UN women. In BRCA1/BRCA2 mutation carriers, surveillance does not influence their initial psychological condition, whereas prophylactic surgery has a significant impact in reducing the perceived risk and worry about getting sick. C-A and C-UN women have to be considered as two separate populations of BRCA mutation carriers requiring personalized approaches to risk management.",
keywords = "BRCA1/BRCA2, Breast cancer, Ovarian cancer, Prophylactic surgery, Psychological impact, Risk perception",
author = "C. Borreani and S. Manoukian and E. Bianchi and C. Brunelli and B. Peissel and A. Caruso and G. Morasso and Pierotti, {M. A.}",
year = "2014",
month = "1",
doi = "10.1111/cge.12298",
language = "English",
volume = "85",
pages = "7--15",
journal = "Clinical Genetics",
issn = "0009-9163",
publisher = "Wiley-Blackwell Publishing Ltd",
number = "1",

}

TY - JOUR

T1 - The psychological impact of breast and ovarian cancer preventive options in BRCA1 and BRCA2 mutation carriers

AU - Borreani, C.

AU - Manoukian, S.

AU - Bianchi, E.

AU - Brunelli, C.

AU - Peissel, B.

AU - Caruso, A.

AU - Morasso, G.

AU - Pierotti, M. A.

PY - 2014/1

Y1 - 2014/1

N2 - This study was performed to describe the impact of preventive options on the psychological condition of BRCA1/BRCA2 carriers. A sample of 52 cancer-affected (C-A) and 27 cancer-unaffected (C-UN) women were enrolled after gene test disclosure (T0). Psychological evaluations were performed at T0 and 15months later (T1). The surgical options were more likely to be chosen in C-A women (62%), although a consistent proportion of C-UN women (30%) also opt for these preventive measures. At the baseline, both samples had average anxiety and depression scores below the cut-off value, restrained average cancer worry scores and a risk perception consistent with the risk percentage provided during genetic counselling. The longitudinal results indicated no clinically meaningful variations in the anxiety and depression scores in either of the two samples. Statistically significant reductions in cancer-risk perception emerged in women who chose surgery in both C-A and C-UN women. In BRCA1/BRCA2 mutation carriers, surveillance does not influence their initial psychological condition, whereas prophylactic surgery has a significant impact in reducing the perceived risk and worry about getting sick. C-A and C-UN women have to be considered as two separate populations of BRCA mutation carriers requiring personalized approaches to risk management.

AB - This study was performed to describe the impact of preventive options on the psychological condition of BRCA1/BRCA2 carriers. A sample of 52 cancer-affected (C-A) and 27 cancer-unaffected (C-UN) women were enrolled after gene test disclosure (T0). Psychological evaluations were performed at T0 and 15months later (T1). The surgical options were more likely to be chosen in C-A women (62%), although a consistent proportion of C-UN women (30%) also opt for these preventive measures. At the baseline, both samples had average anxiety and depression scores below the cut-off value, restrained average cancer worry scores and a risk perception consistent with the risk percentage provided during genetic counselling. The longitudinal results indicated no clinically meaningful variations in the anxiety and depression scores in either of the two samples. Statistically significant reductions in cancer-risk perception emerged in women who chose surgery in both C-A and C-UN women. In BRCA1/BRCA2 mutation carriers, surveillance does not influence their initial psychological condition, whereas prophylactic surgery has a significant impact in reducing the perceived risk and worry about getting sick. C-A and C-UN women have to be considered as two separate populations of BRCA mutation carriers requiring personalized approaches to risk management.

KW - BRCA1/BRCA2

KW - Breast cancer

KW - Ovarian cancer

KW - Prophylactic surgery

KW - Psychological impact

KW - Risk perception

UR - http://www.scopus.com/inward/record.url?scp=84890215608&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84890215608&partnerID=8YFLogxK

U2 - 10.1111/cge.12298

DO - 10.1111/cge.12298

M3 - Article

VL - 85

SP - 7

EP - 15

JO - Clinical Genetics

JF - Clinical Genetics

SN - 0009-9163

IS - 1

ER -